Impact of diabetes mellitus on drug-resistant tuberculosis treatment outcomes in Georgia – Cohort study

M. Kikvidze, L. Mikiashvili (Tbilisi, Georgia)

Source: Annual Congress 2013 –Drug-resistant tuberculosis
Session: Drug-resistant tuberculosis
Session type: Thematic Poster Session
Number: 2826
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Kikvidze, L. Mikiashvili (Tbilisi, Georgia). Impact of diabetes mellitus on drug-resistant tuberculosis treatment outcomes in Georgia – Cohort study. Eur Respir J 2013; 42: Suppl. 57, 2826

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Efficacy of treatment of MDR/XDR TB patients with diabetes mellitus
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015

Impact of diabetes mellitus on clinical parameters and treatment outcomes of diagnosed pulmonary tuberculosis patients
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014


Clinical manifestations and efficacy MDR/XDR tuberculosis in patients with different type’s of diabetes mellitus
Source: International Congress 2015 – Case series and clinical conundrums in TB
Year: 2015


Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis in an endemic area
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013

Addressing the tuberculosis (TB) and diabetes mellitus (DM) co-epidemic among TB patients in Luanda, Angola
Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease
Year: 2016

Tuberculosis and diabetes mellitus: Treatment outcomes using directly observed therapy (DOT)
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015


Screening of diabetes mellitus among new cases of tuberculosis
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013

Comorbidities and MDR-TB treatment outcomes in Georgia- 2009-11 cohort
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014

Factors associated with severity of pulmonary tuberculosis and mortality in TB patients with diabetes mellitus
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014

Diabetes mellitus and pulmonary tuberculosis – Portuguese retrospective cohort
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015


Comparison of the clinical manifestations of tuberculosis in patients with different type’s of diabetes mellitus and without it
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016


Effectiveness of lung surgery in MDR TB patients with diabetes mellitus
Source: International Congress 2016 – Open problems in thoracic surgery
Year: 2016

Tuberculosis with diabetes mellitus: Does delayed sputum conversion always needs MDR evaluation?
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014


Prevalence of diabetes mellitus in new tuberculosis cases in Baghdad
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015


A study of immunogenetic markers associated With tuberculosis and diabetes mellitus
Source: Annual Congress 2013 –Diagnostic features of tuberculosis II
Year: 2013

Risk factors for tuberculosis relapse in Polish patients
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013

Effect of diabetes mellitus on the Time of mycobacterial clearance from sputum during the treatment of multi-drugs resistant tuberculosis
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014


Latent tuberculosis infection prevalence and risk of developing active TB among patients eligible for starting anti-TNFα therapy
Source: International Congress 2015 – Screening strategies in TB
Year: 2015

Predictors of defaulting from treatment among patients with tuberculosis
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015


Treatment outcomes among multidrug-resistant tuberculosis (MDR-TB) cases at a referral hospital of infectious diseases in Italy
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016